| |||||||||
ISMP Canada NewsMay 6, 2021: Safety Bulletin - Hospital Readiness to Use the Antidote Methylene BlueISMP Canada became aware of incidents that described an immediate need for methylene blue as an antidote to treat methemoglobinemia (resulting from sodium nitrate/nitrite exposure). In these urgent situations, there was confusion as to its availability and dosing, resulting in delays in administration. Read more ... |
|||||||||
Copyright © 2000-2016 Institute for Safe Medication Practices Canada (ISMP Canada). All Rights Reserved. |